SCHEMBL13699889

SCHEMBL13699889

CCOc1cccc2c(NC(=O)c3ccc(C)cc3)c(C(N)=O)oc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 6/20 0.60
MAPT P10636 6/20 0.60
MAPK10 P53779 4/20 0.60
HPGD P15428 2/20 0.60
LMNA P02545 2/20 0.60
ALOX15 P16050 1/20 0.60
TSHR P16473 2/20 0.49
HSD17B10 Q99714 2/20 0.49
AHR P35869 1/20 0.49
RXFP1 Q9HBX9 4/20 0.48
ALDH1A1 P00352 3/20 0.47
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
NPSR1 Q6W5P4 1/20 0.44
KDM4E B2RXH2 1/20 0.43
THRB P10828 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13699704 0.92 MAPT (0.60) TP53MAPTMAPK10HPGDLMNA
SCHEMBL13699868 0.91 MAPT (0.59) TP53MAPTMAPK10HPGDLMNA
SCHEMBL13699726 0.90 MAPT (0.53) TP53MAPTMAPK10HPGDLMNA
SCHEMBL13699966 0.88 MAPT (0.64) TP53MAPTMAPK10HPGDLMNA
SCHEMBL13699934 0.86 MAPK10 (0.59) TP53MAPTMAPK10HPGDLMNA
SCHEMBL13699884 0.85 MAPT (0.52) TP53MAPTMAPK10HPGDLMNA
SCHEMBL13699763 0.84 HPGD (0.67) TP53MAPTMAPK10HPGDLMNA
SCHEMBL13699787 0.83 HPGD (0.58) TP53MAPTMAPK10HPGDLMNA
SCHEMBL13699746 0.83 MAPT (0.50) TP53MAPTMAPK10HPGDLMNA
SCHEMBL13699973 0.82 MEN1 (0.56) TP53MAPTMAPK10HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F TP53 4721/4885MAPT 4025/4885MAPK10 3802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.